-
Mashup Score: 0When Africa and Europe Meet in Church - 3 hour(s) ago
It was a glorious wintry day to stroll through New York City’s Central Park, going from west to east, with a blinding sun warming the face. Solo pedestrians were carrying on telephone conversations with invisible others at the other end of the line. Nannies speaking foreign tongues pushed prams across the park as the motion and warmth lulled every baby into a loveable quiet. I was on my way to The Metropolitan Museum of Art (The Met) to follow up on a recommendation from an academic psychiatrist colleague
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0
In my editorial in the previous issue of Psychiatric News, I discussed the risk of socio-cultural factors affecting the integrity of psychedelic clinical trials (PCTs). In light of these substances’ cultural significance, history, and powerful effects (including observable changes in consciousness), rigorous clinical trial design—with randomization, blinding, and control requirements above those typical of nonpsychedelic psychotropic clinical trials—is required. A high level of stringency for psychedelic
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet-
EDITOR'S DESK | In this follow-up editorial, I will review some of the major challenges specific to #psychedelic clinical trials (PCTs) in the domains of randomization, blinding, and control interventions and propose specific solutions. https://t.co/maTpftBroX @APAPsychiatric https://t.co/RHkL0TxDQI
-
-
Mashup Score: 4
Winners of this prestigious award have demonstrated innovative services; a focus on quality improvement; effective use of psychiatrists, peer specialists, and other staff; and involvement of consum…
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 11
Vanda Pharmaceuticals Inc. announced in April that the Food and Drug Administration (FDA) approved the antipsychotic Fanapt (iloperidone) for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Iloperidone has been approved for the acute treatment of schizophrenia since 2009. The approval was based on a phase 3 clinical trial of 414 adults with a history of bipolar I disorder. After four weeks of treatment, patients treated with iloperidone exhibited a 14-point
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 3
The 2024 federal budget includes vital funding for the Department of Health and Human Services, the Department of Labor, and other federal agencies overseeing and implementing mental health and sub…
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 4
Involvement of psychiatrists on an inpatient treatment team was crucial to identifying a safe discharge plan for a patient with opioid use disorder (OUD) with a peripherally inserted central cathet…
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0Microsoft AI Expert: APA, MH Professionals Must Help Guide Future of AI and Mental Health - 2 day(s) ago
The future of artificial intelligence and its impact on psychiatry was prominent among the topics discussed at APA’s Board of Trustees meeting in March.
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 12A Call to Action: Test Our Patients for Hepatitis C - 3 day(s) ago
Psychiatrists need to be knowledgeable about hepatitis C, as it is associated with various psychiatric and neuropsychiatric symptoms, and patients are at increased risk for this infection.
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 5White House Calls for Stakeholder Action on Overdose Deaths - 3 day(s) ago
The Biden administration has challenged organizations and businesses of all sizes to help keep their employees, customers, and communities safe with improved access to opioid overdose reversal medi…
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 12
Eleven years after I began working the most rewarding job I could imagine, it is time for me to say goodbye as CEO and medical director of APA. It has been a remarkable journey, made memorable by challenges, opportunities, surprises, and a few setbacks, but also by many achievements; at every point I have been sustained by the support and expertise of the extraordinary APA leadership—Board and Assembly members; presidents, past and present; component members; and the best administration a CEO could ask
Source: psychnews.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
ON MENTAL HEALTH, PEOPLE, AND PLACES | My decades-long interest in this religious group is described in Ye Shall Dream. Commentators have noted the movement’s emphasis on liberation theology and improving members’ self-esteem and independence of thought. https://t.co/7IsSQO45nl https://t.co/E1U1VooHPX